FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2939764897> ?p ?o ?g. }

• W2939764897 endingPage "896" @default.
• W2939764897 startingPage "889" @default.
• W2939764897 abstract "BackgroundCurrent guidelines support cancer-directed surgery, chemotherapy, or active surveillance for clinical stages 1 to 3 of epithelial malignant pleural mesothelioma (MPM). Definitive chemotherapy is recommended for sarcomatoid/biphasic histologies. Our objective is to assess compliance with recommendations, measuring their impact on overall survival.MethodsThe National Cancer Database participant user file (2004 to 2014) was queried for patients diagnosed with MPM clinical stages 1 to 3. Multivariable logistic regression model identified factors independently associated with guideline compliance. Kaplan-Meier analysis and Cox proportional hazards were used for overall survival comparison with histologic subgroup analysis.ResultsA total of 3419 patients with clinical stages 1 to 3 met criteria for analysis and comprised epithelial (68.5%), sarcomatoid (17.2%), and biphasic subtypes (14.3%). Cancer-directed surgery was significantly underutilized in epithelial MPM, with 29.3% having no treatment. On multivariable analysis, insurance status and facility type were the strongest predictors of guideline compliance. High-volume hospitals were the most compliant with guidelines (odds ratio 3.58, 95% confidence interval (CI), 2.34 to 5.49, P < .001). Median survival estimates for no treatment, chemotherapy alone, surgery plus chemotherapy, and trimodal therapy were 10.2, 15.4, 21.1, and 21.7 months, respectively (log rank P < .001). In epithelial MPM, a significant increase in overall survival was observed in surgery plus chemotherapy (hazard ratio 0.62, 95% CI, 0.53 to 0.73, P < .001) and trimodality (hazard ratio 0.61, 95% CI, 0.49 to 0.76, P < .001; reference: no treatment).ConclusionsThere is a suboptimal compliance with national guidelines for the treatment of MPM, particularly in low-volume nonacademic settings. Adherence to recommended surgery-based multimodal therapy is associated with an overall survival improvement. Current guidelines support cancer-directed surgery, chemotherapy, or active surveillance for clinical stages 1 to 3 of epithelial malignant pleural mesothelioma (MPM). Definitive chemotherapy is recommended for sarcomatoid/biphasic histologies. Our objective is to assess compliance with recommendations, measuring their impact on overall survival. The National Cancer Database participant user file (2004 to 2014) was queried for patients diagnosed with MPM clinical stages 1 to 3. Multivariable logistic regression model identified factors independently associated with guideline compliance. Kaplan-Meier analysis and Cox proportional hazards were used for overall survival comparison with histologic subgroup analysis. A total of 3419 patients with clinical stages 1 to 3 met criteria for analysis and comprised epithelial (68.5%), sarcomatoid (17.2%), and biphasic subtypes (14.3%). Cancer-directed surgery was significantly underutilized in epithelial MPM, with 29.3% having no treatment. On multivariable analysis, insurance status and facility type were the strongest predictors of guideline compliance. High-volume hospitals were the most compliant with guidelines (odds ratio 3.58, 95% confidence interval (CI), 2.34 to 5.49, P < .001). Median survival estimates for no treatment, chemotherapy alone, surgery plus chemotherapy, and trimodal therapy were 10.2, 15.4, 21.1, and 21.7 months, respectively (log rank P < .001). In epithelial MPM, a significant increase in overall survival was observed in surgery plus chemotherapy (hazard ratio 0.62, 95% CI, 0.53 to 0.73, P < .001) and trimodality (hazard ratio 0.61, 95% CI, 0.49 to 0.76, P < .001; reference: no treatment). There is a suboptimal compliance with national guidelines for the treatment of MPM, particularly in low-volume nonacademic settings. Adherence to recommended surgery-based multimodal therapy is associated with an overall survival improvement." @default.
• W2939764897 created "2019-04-25" @default.
• W2939764897 creator A5022683685 @default.
• W2939764897 creator A5022720584 @default.
• W2939764897 creator A5029460219 @default.
• W2939764897 creator A5038515609 @default.
• W2939764897 creator A5043921934 @default.
• W2939764897 creator A5045063913 @default.
• W2939764897 creator A5063684299 @default.
• W2939764897 date "2019-09-01" @default.
• W2939764897 modified "2023-09-27" @default.
• W2939764897 title "Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma" @default.
• W2939764897 cites W1977376622 @default.
• W2939764897 cites W1979705049 @default.
• W2939764897 cites W2017959023 @default.
• W2939764897 cites W2040838599 @default.
• W2939764897 cites W2079060301 @default.
• W2939764897 cites W2102369588 @default.
• W2939764897 cites W2118180003 @default.
• W2939764897 cites W2138270921 @default.
• W2939764897 cites W2146280723 @default.
• W2939764897 cites W2151595445 @default.
• W2939764897 cites W2156058184 @default.
• W2939764897 cites W2157557999 @default.
• W2939764897 cites W2158408253 @default.
• W2939764897 cites W2604369263 @default.
• W2939764897 cites W2745499313 @default.
• W2939764897 cites W2747031576 @default.
• W2939764897 cites W2783708904 @default.
• W2939764897 doi "https://doi.org/10.1016/j.athoracsur.2019.03.052" @default.
• W2939764897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31004585" @default.
• W2939764897 hasPublicationYear "2019" @default.
• W2939764897 type Work @default.
• W2939764897 sameAs 2939764897 @default.
• W2939764897 citedByCount "9" @default.
• W2939764897 countsByYear W29397648972019 @default.
• W2939764897 countsByYear W29397648972020 @default.
• W2939764897 countsByYear W29397648972021 @default.
• W2939764897 countsByYear W29397648972022 @default.
• W2939764897 countsByYear W29397648972023 @default.
• W2939764897 crossrefType "journal-article" @default.
• W2939764897 hasAuthorship W2939764897A5022683685 @default.
• W2939764897 hasAuthorship W2939764897A5022720584 @default.
• W2939764897 hasAuthorship W2939764897A5029460219 @default.
• W2939764897 hasAuthorship W2939764897A5038515609 @default.
• W2939764897 hasAuthorship W2939764897A5043921934 @default.
• W2939764897 hasAuthorship W2939764897A5045063913 @default.
• W2939764897 hasAuthorship W2939764897A5063684299 @default.
• W2939764897 hasBestOaLocation W29397648971 @default.
• W2939764897 hasConcept C121608353 @default.
• W2939764897 hasConcept C126322002 @default.
• W2939764897 hasConcept C141071460 @default.
• W2939764897 hasConcept C142724271 @default.
• W2939764897 hasConcept C143998085 @default.
• W2939764897 hasConcept C156957248 @default.
• W2939764897 hasConcept C207103383 @default.
• W2939764897 hasConcept C2776694085 @default.
• W2939764897 hasConcept C2777407522 @default.
• W2939764897 hasConcept C2780182762 @default.
• W2939764897 hasConcept C44249647 @default.
• W2939764897 hasConcept C50382708 @default.
• W2939764897 hasConcept C71924100 @default.
• W2939764897 hasConceptScore W2939764897C121608353 @default.
• W2939764897 hasConceptScore W2939764897C126322002 @default.
• W2939764897 hasConceptScore W2939764897C141071460 @default.
• W2939764897 hasConceptScore W2939764897C142724271 @default.
• W2939764897 hasConceptScore W2939764897C143998085 @default.
• W2939764897 hasConceptScore W2939764897C156957248 @default.
• W2939764897 hasConceptScore W2939764897C207103383 @default.
• W2939764897 hasConceptScore W2939764897C2776694085 @default.
• W2939764897 hasConceptScore W2939764897C2777407522 @default.
• W2939764897 hasConceptScore W2939764897C2780182762 @default.
• W2939764897 hasConceptScore W2939764897C44249647 @default.
• W2939764897 hasConceptScore W2939764897C50382708 @default.
• W2939764897 hasConceptScore W2939764897C71924100 @default.
• W2939764897 hasFunder F4320313996 @default.
• W2939764897 hasFunder F4320337585 @default.
• W2939764897 hasIssue "3" @default.
• W2939764897 hasLocation W29397648971 @default.
• W2939764897 hasOpenAccess W2939764897 @default.
• W2939764897 hasPrimaryLocation W29397648971 @default.
• W2939764897 hasRelatedWork W2022392719 @default.
• W2939764897 hasRelatedWork W2096645291 @default.
• W2939764897 hasRelatedWork W2119154902 @default.
• W2939764897 hasRelatedWork W2133235702 @default.
• W2939764897 hasRelatedWork W2203903734 @default.
• W2939764897 hasRelatedWork W2804529914 @default.
• W2939764897 hasRelatedWork W3017329712 @default.
• W2939764897 hasRelatedWork W3038392370 @default.
• W2939764897 hasRelatedWork W3154231528 @default.
• W2939764897 hasRelatedWork W3162666314 @default.
• W2939764897 hasVolume "108" @default.
• W2939764897 isParatext "false" @default.
• W2939764897 isRetracted "false" @default.
• W2939764897 magId "2939764897" @default.
• W2939764897 workType "article" @default.